Literature DB >> 8922074

Symptomatology of Helicobacter pylori infection in children.

U Blecker1, B Hauser, S Lanciers, K Keymolen, Y Vandenplas.   

Abstract

In a retrospective evaluation we reviewed the symptomatology of 143 children (age 2-15 years, mean 8.9 years) who were referred to us for upper gastrointestinal endoscopy because of recurrent abdominal pain with a duration of 6 weeks or longer. Helicobacter pylori infection was diagnosed in 36 out of 143 patients (25.2%). No statistically significant differences could be detected between the symptoms experienced by the 36 H. pylori-infected children and those experienced by the remaining 107 H. pylori-negative pediatric patients (p = 0.18-0.60). We conclude that no specific symptoms are associated with H. pylori gastritis in children. Our observations suggest that the recurrent abdominal complaints found in children with H. pylori infection seem to be caused by the secondary gastroduodenal pathology, rather than by H. pylori infection itself.

Entities:  

Mesh:

Year:  1996        PMID: 8922074     DOI: 10.1111/j.1651-2227.1996.tb18220.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

Review 1.  Presentation and management of Helicobacter pylori infection in childhood.

Authors:  U Blecker; N K Mittal; D I Mehta
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Seroepidemiology of Helicobacter pylori infection among asymptomatic Chinese children.

Authors:  Chun-Di Xu; Shun-Nian Chen; Shi-Hu Jiang; Jia-Yu Xu
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  Endoscopic and histopathologic findings associated with H. pylori infection in very young children.

Authors:  Engin Tutar; Deniz Ertem; Esin Kotiloglu Karaa; Ender Pehlivanoglu
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.